A Trial of Pembrolizumab and Metformin Versus Pembrolizumab Alone in Advanced Melanoma
Clinical trial NCT03311308 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03311308
- Sponsor
- Yana Najjar
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-07
- Primary completion
- 2028-01-31
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.